Alcohol takes the toll on immune function

Liver International

Volumn 30, Issue 7, 2010, Pages 934-936

  Stadlbauer, Vanessa ^a   Shah, Naina ^b   de Oca Arjona, Montserrat Montes ^b   Mookerjee, Rajeshwar Prosad ^b   Jalan, Rajiv ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACTERIAL DNA; CD14 ANTIGEN; ENDOTOXIN; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; ACUTE PHASE PROTEIN; CARRIER PROTEIN; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ALCOHOL LIVER CIRRHOSIS; BACTEREMIA; CYTOKINE RELEASE; EDITORIAL; ENDOTOXEMIA; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; UPREGULATION; ALCOHOL LIVER DISEASE; BLOOD; CHRONIC DISEASE; DRINKING BEHAVIOR; IMMUNOLOGY; MONONUCLEAR CELL;

ACUTE-PHASE PROTEINS; ALCOHOL DRINKING; ANTIGENS, CD14; CARRIER PROTEINS; CHRONIC DISEASE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIVER DISEASES, ALCOHOLIC; MEMBRANE GLYCOPROTEINS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957153159     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02271.x     Document Type: Editorial

References (20)

1. Navasa M, Fernandez J, Rodes J. Bacterial infections in liver cirrhosis. Ital J Gastroenterol Hepatol 1999, 31:616-25.
2. Linderoth G, Jepsen P, Schonheyder HC, Johnsen SP, Sorensen HT. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: a population-based cohort study. Alcohol Clin Exp Res 2006, 30:636-41.
3. Pimentel-Nunes P, Roncon-Albuquerque R, Gonçalves N. Attenuation of toll-like receptor 2 mediated innate immune response in patients with alcoholic chronic liver disease. Liver Int 2010, 30:1003-11.
4. Jarvelainen HA, Fang C, Ingelman-Sundberg M, Lindros KO. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 1999, 29:1503-10.
5. Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological " damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem 2006, 13:2487-502.
6. Mookerjee R, Stadlbauer V, Lidder S. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology 2007, 46:831-40.
7. Stadlbauer V, Mookerjee RP, Wright GA. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2009, 296:G15-22.
8. Manigold T, Bocker U, Hanck C. Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2003, 15:275-82.
9. Riordan SM, Skinner N, Nagree A. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003, 37:1154-64.
10. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int 2006, 26:912-9.
11. Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A. Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom 2007, 72:408-15.
12. Mandrekar P, Bala S, Catalano D, Kodys K, Szabo G. The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes. J Immunol 2009, 183:1320-7.
13. Taieb J, Mathurin P, Elbim C. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids. J Hepatol 2000, 32:579-86.
14. Feliu E, Gougerot MA, Hakim J. Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis. Eur J Clin Invest 1977, 7:571-7.
15. Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000, 182:526-33.
16. Malik R, Mookerjee RP, Jalan R. Infection and inflammation in liver failure: two sides of the same coin. J Hepatol 2009, 51:426-9.
17. Berres ML, Schnyder B, Yagmur E. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int 2009, 29:536-43.
18. Lin CY, Tsai IF, Ho YP. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 2007, 46:816-26.
19. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005, 41:422-33.
20. Frances R, Zapater P, Gonzalez-Navajas JM. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 2008, 47:978-85.